Elpamotide

Contact Us

Products

Quote Request

Catalog No.: PC0191

Size: 50 mg, 100mg, 250mg

Description

Elpamotide is an epitope peptide derived from VEGFR2. Elpamotide induces cytotoxic T lymphocytes (CTL) to kill VEGFR2-expressing endothelial cells. Elpamotide has potential immunostimulatory and antitumor activity. Ipamotide is used in cancer research, such as pancreatic cancer.

Molecular Weight	1073.21
Formula	C47H76N16O13
CAS No.	673478-49-4
Sequence	RFVPDGNRI
Shipping	Room temperature in continental US; may vary elsewhere.
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.

All of our services are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

As science and technology continue to evolve, Alfa Cytology, as a provider of preclinical research services, is committed to maintaining the pace of progress, providing pancreatic cancer-related solutions that leverage existing resources to help our customers accelerate research and development.

By Molecule Type

By Research Phase

Company